A Survey of Aging Research
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cryonics Magazine, Q1 2001
SOURCE FEATURES PAGE Fred Chamberlain Glass Transitions: A Project Proposal 3 Mike Perry Interview with Dr. Jerry Lemler, M.D. 13 Austin Esfandiary A Tribute to FM-2030 16 Johnny Boston FM & I 18 Billy H. Seidel the ALCOR adventure 39 Natasha Vita-More Considering Aesthetics 45 Columns Book Review: Affective Computing..................................41 You Only Go Around Twice .................................................42 First Thoughts on Last Matters............................................48 TechNews.......................................................................51 Alcor update - 19 The Global Membership Challenge . 19 Letter from Steve Bridge . 26 President’s Report . 22 “Last-Minute” Calls . 27 Transitions and New Developments . 24 Alcor Membership Status . 37 1st Qtr. 2001 • Cryonics 1 Alcor: the need for a rescue team or even for ingly evident that the leadership of The Origin of Our Name cryonics itself. Symbolically then, Alcor CSC would not support or even would be a “test” of vision as regards life tolerate a rescue team concept. Less In September of 1970 Fred and extension. than one year after the 1970 dinner Linda Chamberlain (the founders of As an acronym, Alcor is a close if meeting, the Chamberlains severed all Alcor) were asked to come up with a not perfect fit with Allopathic Cryogenic ties with CSC and incorporated the name for a rescue team for the now- Rescue. The Chamberlains could have “Rocky Mountain Cryonics Society” defunct Cryonics Society of California forced a five-word string, but these three in the State of Washington. The articles (CSC). In view of our logical destiny seemed sufficient. Allopathy (as opposed and bylaws of this organization (the stars), they searched through star to Homeopathy) is a medical perspective specifically provided for “Alcor catalogs and books on astronomy, wherein any treatment that improves the Members,” who were to be the core of hoping to find a star that could serve as prognosis is valid. -
Human Cell and Organism Aging: Are There Limits? Interrupted Case Study on Cell Aging
Human Cell and Organism Aging: Are there Limits? Interrupted Case study on Cell Aging Teresa Gonya Department of Biological Sciences University of Wisconsin-Fox Valley Menasha, WI The search for the fountain of youth persists in advertising, and individuals are constantly bombarded with messages about diet, exercise, vitamins and minerals that can help prolong one’s life. The biological basis of aging is often not mentioned in the anti-aging promotions. Is it possible that a diet rich in protein, or fruits and vegetables can add years to your life? Is it possible that a vitamin or mineral ‘tonic’ can promote tissue repair and extend life? Is it possible that a vitamin drink can extend your normal life expectancy? Even clinical medicine focuses on developing new treatments that are based on preventing aging and maintaining organ longevity. We are told to exercise to keep our heart healthy and to stop smoking to prevent damage to body tissues, especially the lungs and blood vessels. The new field of regenerative medicine is based on the premise that stem cells may one day be able to repair tissue and return function to damaged organs. There are real limits to longevity that are based on genetics, lifestyle, medical history and sociology. (1) At the foundation of organism longevity is cell longevity. All organisms are composed of cells. Four different types of tissue cells form the basis of all organs that are found in any animal organism. Each type of tissue cell has a different ability to undergo mitosis and replace itself, should it become damaged or injured. -
From Here to Immortality: Anti-Aging Medicine
FromFrom HereHere toto Immortality:Immortaalitty: AAnti-AgingAnnntti-AAgging MMedicineedicine Anti-aging medicine is a $5 billion industry. Despite its critics, researchers are discovering that inter ventions designed to turn back time may prove to be more science than fiction. By Trudie Mitschang 14 BioSupply Trends Quarterly • October 2013 he symptoms are disturbing. Weight gain, muscle Shifting Attitudes Fuel a Booming Industry aches, fatigue and joint stiffness. Some experience The notion that aging requires treatment is based on a belief Thear ing loss and diminished eyesight. In time, both that becoming old is both undesirable and unattractive. In the memory and libido will lapse, while sagging skin and inconti - last several decades, aging has become synonymous with nence may also become problematic. It is a malady that begins dete rioration, while youth is increasingly revered and in one’s late 40 s, and currently 100 percent of baby boomers admired. Anti-aging medicine is a relatively new but thriving suffer from it. No one is immune and left untreated ; it always field driven by a baby- boomer generation fighting to preserve leads to death. A frightening new disease, virus or plague? No , its “forever young” façade. According to the market research it’s simply a fact of life , and it’s called aging. firm Global Industry Analysts, the boomer-fueled consumer The mythical fountain of youth has long been the subject of base will push the U.S. market for anti-aging products from folklore, and although it is both natural and inevitable, human about $80 billion now to more than $114 billion by 2015. -
Etergen Whitepaper.Pages
ETERGEN WHITE PAPER Executive Summary I. Brief History II. The problem III. Solution – business model IV. Token offer V. Our Accountability with Your investments VI. Timeline VII. Our Team Disclamer The ETERGEN Foundation – Live longer. Executive Summary At Eternity foundation we believe that human life is precious. And we want you and your loved ones to live longer. In fact, we are doing everything we can for it, through supporting scientific research in the field of human life extension. With technology and knowledge our society has now, we all can live a longer, healthier life, only if the needed attention was paid to the financing of the research in the field of life extension. We support international medical and scientific research, aimed at human life extension, with system of grants and investments for the best projects. We believe that significant human life extension can be reached within our lifetime. To finance this research, we offer our own cryptocurrency, THE ETER. THE ETER is state of the art cryptocurrency giving you the lowest cost per transaction and true anonymous security . Not only will the ETER help the mankind to solve the most important question we face, but it will also create great value for all the currency holders, since every project, financed by us, will have a contract obligation to share the profits with all the holders. This will be guaranteed through use of smart contracts utilizing the blockchain technology. "1 ETERGEN WHITE PAPER We will build up the industry of human life extension through introducing cutting edge technology. Our key advantages are: A global project A growing multibillion industry with huge growth potential Real value behind the currency Experienced team with high qualifications Unique idea - there is no other project like this. -
Telomeres and Telomerase
Oncogene (2010) 29, 1561–1565 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 $32.00 www.nature.com/onc GUEST EDITORIAL 2009 Nobel Prize in Physiology or Medicine: telomeres and telomerase Oncogene (2010) 29, 1561–1565; doi:10.1038/onc.2010.15 sate for the chromosomal shortening produced asso- ciated with cell division, suggesting that progressive telomere shortening may be a key factor to limit the Elizabeth H Blackburn, Carol W Greider and Jack W number of cell divisions. James D Watson (Nobel Prize Szostak were acknowledged with this year’s Nobel Prize 1962) also recognized that the unidirectional nature of in Physiology or Medicine for their discoveries on how DNA replication was a problem for the complete copy chromosomes are protected by telomeres and the of chromosomal ends (Watson, 1972). This was called enzyme telomerase. the ‘end-replication problem’. In this manner, during In the first half of the twentieth century, classic studies each cycle of cell division, a small fragment of telomeric by Hermann Mu¨ller (Nobel Prize 1945) working with DNA is lost from the end. After several rounds of the fruit fly (Drosophila melanogaster) and by Barbara division, telomeres eventually reach a critically short McClintock (Nobel Prize 1983) studying maize (Zea length, which activates the pathways for senescence and Mays) proposed the existence of a special structure at cell death (Hermann et al., 2001; Samper et al., 2001). the chromosome ends (Mu¨ller, 1938; McClintock, 1939). Uncovering the solution to the end-replication pro- This structure would have the essential role of protect- blem took several years of intense research. -
Anti-Aging 2018
Anti-Aging 2018 Altern verstehen Altern messen Altern behandeln Prof. Dr. Bernd Kleine-Gunk Präsident der Deutschen Gesellschaft für Präventions- und Anti-Aging Medizin (GSAAM) www. kleine-gunk.de Metropol Medical Center Nürnberg Ist Altern eine Krankheit? www. kleine-gunk.de Metropol Medical Center Nürnberg Risikofaktor biologisches Lebensalter ESC Score – Kardiovaskuläre Erkrankungen ¹ DeBacker G et al. European guidelines on cardiovascular disease prevention in clinical practice. The Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts) executive summary. Eur Heart J 2003; 24: 1601–10. www. kleine-gunk.de Metropol Medical Center Nürnberg Risikofaktor biologisches Lebensalter AGLA Score – Kardiovaskuläre Erkrankungen Eur J Clin Invest. 2007; 37:925-32 www. kleine-gunk.de Metropol Medical Center Nürnberg www. kleine-gunk.de www. Heft 39,2006: 2542-2548 Häusler,Gothe, Göl, Glaeske,Pientka, Felsenberg,Dtsch. Ärzteblatt 103, Jg [%] Anteil der Patienten mit Osteoporose Risikofaktor Lebensalter biologisches 7% 7% 7% 7% 1,3 Mio1,3 Männer 1,3 Mio1,3 Männer Osteoporose in Deutschland in Osteoporose > 75> Jahre 65–74Jahre 50–64Jahre > 75> Jahre 65–74Jahre 50–64Jahre 11% 11% 11% 11% 16% 16% 16% 16% 23% 23% 23% 23% 6,5 Mio Frauen 6,5 Mio Frauen 47% 47% 47% 47% 59% 59% 59% 59% Nürnberg Center Medical Metropol Risikofaktor biologisches Lebensalter Altersabhängige Häufigkeit der Demenz http://www.alzheimerinfo.de/alzheimer/zahlen/index.jsp www. kleine-gunk.de Metropol Medical Center Nürnberg Risikofaktor biologisches Lebensalter Bösartige Neuerkrankungen nach Alter 1989 bis 1998 im Saarland Frauen Quelle der Statistik: Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland. -
Living to 100”
The Likelihood and Consequences of “Living to 100” Leonard Hayflick, Ph.D. Professor of Anatomy, Department of Anatomy University of California, San Francisco, School of Medicine Phone: (707) 785-3181 Fax: (707) 785-3809 Email: [email protected] Presented at the Living to 100 Symposium Orlando, Fla. January 5-7, 2011 Copyright 2011 by the Society of Actuaries. All rights reserved by the Society of Actuaries. Permission is granted to make brief excerpts for a published review. Permission is also granted to make limited numbers of copies of items in this monograph for personal, internal, classroom or other instructional use, on condition that the foregoing copyright notice is used so as to give reasonable notice of the Society’s copyright. This consent for free limited copying without prior consent of the Society does not extend to making copies for general distribution, for advertising or promotional purposes, for inclusion in new collective works or for resale. Abstract There is a common belief that it would be a universal good to discover how to slow or stop the aging process in humans. It guides the research of many biogerontologists, the course of some health policy leaders and the hopes of a substantial fraction of humanity. Yet, the outcome of achieving this goal is rarely addressed despite the fact that it would have profound consequences that would affect virtually every human institution. In this essay, I discuss the impact on human life if a means were found to slow our aging process, thus permitting a life expectancy suggested by the title of this conference, “Living to 100.” It is my belief that most of the consequences would not benefit either the individual or society. -
Controversy 2
Controversy 2 WHY DO OUR BODIES GROW OLD? liver Wendell Holmes (1858/1891), in his poem “The Wonderful One-Hoss Shay,” invokes a memorable image of longevity and mortality, the example of a wooden Ohorse cart or shay that was designed to be long-lasting: Have you heard of the wonderful one-hoss shay, That was built in such a logical way, It ran a hundred years to a day . ? This wonderful “one-hoss shay,” we learn, was carefully built so that every part of it “aged” at the same rate and didn’t wear out until the whole thing fell apart all at once. Exactly a century after the carriage was produced, the village parson was driving this marvelous machine down the street, when What do you think the parson found, When he got up and stared around? The poor old chaise in a heap or mound, As if it had been to the mill and ground! You see, of course, if you’re not a dunce, How it went to pieces all at once, All at once, and nothing first, Just as bubbles do when they burst. The wonderful one-horse shay is the perfect image of an optimistic hope about aging: a long, healthy existence followed by an abrupt end of life, with no decline. The one-horse shay image also suggests that life has a built-in “warranty expiration” date. But where does this limit on longevity come from? Is it possible to extend life beyond what we know? The living organism with the longest individual life span is the bristlecone pine tree found in California, more than 4,500 years old, with no end in sight. -
Cellular Aging: Theories and Technological Influence
1319 Vol.53, n. 6: pp.1319-1332, November-December 2010 BRAZILIAN ARCHIVES OF ISSN 1516-8913 Printed in Brazil BIOLOGY AND TECHNOLOGY AN INTERNATIONAL JOURNAL Cellular Aging: Theories and Technological Influence Silvia Mercado-Sáenz, Miguel J. Ruiz-Gómez *, Francisco Morales-Moreno and Manuel Martínez-Morillo Laboratory of Radiobiology; Department of Radiology and Physical Medicine; Faculty of Medicine; University of Malaga; Teatinos s/n; 29071 - Malaga - Spain ABSTRACT The aim of this article was to review the factors that influence the aging, relationship of aging with the biological rhythms and new technologies as well as the main theories to explain the aging, and to analysis the causes of aging. The theories to explain the aging could be put into two groups: those based on a program that controlled the regression of the organism and those that postulated that the deterioration was due to mutations. It was concluded that aging was a multifactorial process. Genetic factors indicated the maximum longevity of the individual and environmental factors responsible for the real longevity of the individual. It would be necessary to guarantee from early age the conservation of a natural life rhythm. Key words: Aging; longevity; biological rhythms; caloric restriction; telomerase; free radical INTRODUCTION Several theories have been proposed to explain the nature of aging. Due to the multicasual nature of this Aging is the process of becoming older. This process, it turns out improbable that only one theory traditional definition was recently challenged in the could explain all its mechanisms. It is necessary to new encyclopedia of Gerontology (Birren, 2006), bear two important points in mind: (1) the process of where aging was specifically defined as the process aging compromises a number of different genes, and of a system's deterioration through time. -
Ray Kurzweil Reader Pdf 6-20-03
Acknowledgements The essays in this collection were published on KurzweilAI.net during 2001-2003, and have benefited from the devoted efforts of the KurzweilAI.net editorial team. Our team includes Amara D. Angelica, editor; Nanda Barker-Hook, editorial projects manager; Sarah Black, associate editor; Emily Brown, editorial assistant; and Celia Black-Brooks, graphics design manager and vice president of business development. Also providing technical and administrative support to KurzweilAI.net are Ken Linde, systems manager; Matt Bridges, lead software developer; Aaron Kleiner, chief operating and financial officer; Zoux, sound engineer and music consultant; Toshi Hoo, video engineering and videography consultant; Denise Scutellaro, accounting manager; Joan Walsh, accounting supervisor; Maria Ellis, accounting assistant; and Don Gonson, strategic advisor. —Ray Kurzweil, Editor-in-Chief TABLE OF CONTENTS LIVING FOREVER 1 Is immortality coming in your lifetime? Medical Advances, genetic engineering, cell and tissue engineering, rational drug design and other advances offer tantalizing promises. This section will look at the possibilities. Human Body Version 2.0 3 In the coming decades, a radical upgrading of our body's physical and mental systems, already underway, will use nanobots to augment and ultimately replace our organs. We already know how to prevent most degenerative disease through nutrition and supplementation; this will be a bridge to the emerging biotechnology revolution, which in turn will be a bridge to the nanotechnology revolution. By 2030, reverse-engineering of the human brain will have been completed and nonbiological intelligence will merge with our biological brains. Human Cloning is the Least Interesting Application of Cloning Technology 14 Cloning is an extremely important technology—not for cloning humans but for life extension: therapeutic cloning of one's own organs, creating new tissues to replace defective tissues or organs, or replacing one's organs and tissues with their "young" telomere-extended replacements without surgery. -
Caloric Restriction for Longevity: II—The Systematic Neglect of Behavioural and Psychological Outcomes in Animal Research Kelly M
European Eating Disorders Review Eur. Eat. Disorders Rev. 12, 338–360 (2004) Invited Article Caloric Restriction for Longevity: II—The Systematic Neglect of Behavioural and Psychological Outcomes in Animal Research Kelly M. Vitousek1*,y, Frederic P. Manke1, Jennifer A. Gray1 and Maren N. Vitousek2 1University of Hawaii, USA 2Princeton University, USA Research on caloric restriction for longevity (CRL) has generated hundreds of articles on the physiology of food deprivation, yet almost no data on consequences in other domains. The first paper in this series outlined the generally positive physical effects of CRL; the second analyses the meagre and sometimes disturbing record of research on behaviour, cognition and affect. The available evidence suggests that nutrient-dense CRL in animals—just like nutrient- poor semi-starvation in people—is associated with a number of adverse effects. Changes include abnormal food-related behaviour, heightened aggression and diminished sexual activity. Studies of learning and memory in underfed rodents yield inconsistent findings; no information is available on cognitive effects in primates. To date, the CRL field has ignored other variables that are crucial to the human case and known to be disrupted by chronic hunger, including sociability, curiosity and emotionality. Promo- tion of CRL for people is irresponsible in the absence of more reassuring data on the full range of expected outcomes. Eating disorder specialists should be contributing to scientific and public discussions of this increasingly prominent paradigm. Copyright # 2004 John Wiley & Sons, Ltd and Eating Disorders Association. Keywords: dietary restriction; ageing; eating disorders; semi-starvation; hunger; animal aggression; mimetics INTRODUCTION in the active and upbeat field of caloric restriction for longevity (CRL). -
Longevidad Y Envejecimiento En El Tercer Milenio: Nuevas Perspectivas
LONGEVIDAD Y ENVEJECIMIENTO EN EL TERCER MILENIO: NUEVAS PERSPECTIVAS JOSÉ MIGUEL RODRÍGUEZ-PARDO DEL CASTILLO ANTONIO LÓPEZ FARRÉ LONGEVIDAD Y ENVEJECIMIENTO EN EL TERCER MILENIO: NUEVAS PERSPECTIVAS José Miguel Rodríguez-Pardo del Castillo Profesor del Máster en Ciencias Actuariales y Financieras Universidad Carlos III, Madrid Antonio López Farré Profesor de la Facultad de Medicina. Departamento de Medicina. Codirector del Aula AINTEC Universidad Complutense de Madrid Fundación MAPFRE no se hace responsable del contenido de esta obra, ni el hecho de publicarla implica conformidad o identificación con las opiniones vertidas en ella. Reservados todos los derechos. Está prohibido reproducir o transmitir esta publicación, total o parcialmente, por cualquier medio, sin la autorización expresa de los editores, bajo las sanciones establecidas en las leyes. Imágenes de cubierta e interiores: ThinkStock Maquetación e impresión: Edipack Gráfico © De los textos: sus autores © De esta edición: 2017, Fundación MAPFRE Paseo de Recoletos, 23 28004 Madrid www.fundacionmapfre.org ISBN: 978-84-9844-648-7 Depósito Legal: M-18221-2017 «Los hombres son como los vinos: la edad agria los malos y mejora los buenos». Marco Tulio Cicerón «Solo la alegría es señal de salud y longevidad». Santiago Ramón y Cajal «No anheléis la inmortalidad, pero agotad el límite de lo posible». Píndaro Agradecimiento: Los autores quieren agradecer a Begoña Larrea Cruz su excelente y dedicada labor en la edición de esta obra, sin cuya ayuda no hubiera sido nunca finalizada. PRESENTACIÓN Desde 1975 Fundación MAPFRE desarrolla actividades de interés general para la sociedad en distintos ámbitos profesionales y culturales, así como ac- ciones destinadas a la mejora de las condiciones económicas y sociales de las personas y de los sectores menos favorecidos de la sociedad.